Diabetes News Archive

Eating cake and really savouring it! Diabetes New Zealandstaff intend to hold a specialparty in celebration of its 47thbirthday.

GlaxoSmithKline PLC said it had started large-scale Phase 3 clinical trials to evaluate the safety and efficacy of its Type 2 diabetes drug Syncria.

Human Genome Sciences Inc., which licensed its experimental diabetes treatment to GlaxoSmithKline PLC five years ago, will get a $9 million milestone payment as clinical trials advance. (HGSI)

DUBLIN, Ireland----Research and Markets has announced the addition of the "Diabetes Drug Discoveries 2009: what the future holds" report to their offering.

Novo Nordisk, a global healthcare company focusing on diabetes care, today announced the appointment of Andy Ajello as vice president for National Diabetes Sales, Managed Care and Government Accounts.

GlaxoSmithKline today announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and tolerability of the investigational GLP-1 agonist Syncria(R) in men and women with type 2 diabetes.

Children with diabetes are at increased risk of severe hypoglycaemic episodes and long-term complications such as blindness, kidney failure or amputations because paediatric diabetes specialist nurses (PDSNs) are severely overstretched, according to a report released by leading health charity Diabetes UK.

Washington, Feb 17 : For the first time, terminally ill rodents with type-1 diabetes have been restored to complete health with a single injection of a substance other than insulin.

DALLAS, Feb. 17 (UPI) -- Cherries, a super fruit, may reduce factors associated with heart disease and diabetes, a U.S. researcher suggests.

Diabetes is a problem all across America.